I really do not see any short term catalysts moving this to .20 or above outside of a lympro order i dont see amything moving it at all....i think 2016 2017 will be monumental years but i expect near term significant dilution to pay for our acquisitions...elto partner will be 2016 imo no buyout or partner for diagnostics in 2015 imo
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links